According to the predicted BKG-based MOA paths (see Fig. 6D), isradipine may have a potential therapeutic effect for HD by mainly regulating the genes of the calcium voltage-gated channel, including CACNA1C and CACNB2. Here, CACNB2 is linked to Huntington disease.